Comparison Chart Repligen Corporation
Stocks
RGEN
US7599161095
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
12:23:53 2026-08-24 EDT
|
5-day change | 1st Jan Change | ||
| 181.60 USD | +0.26% |
|
+7.54% | +10.94% |
| 09:10am | Azenta Names Board Member Martin Madaus as Interim CEO | MT |
| 07-29 | Tranche Update on Repligen Corporation's Equity Buyback Plan announced on June 18, 2008. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REPLIGEN CORPORATION | Other Medical Equipment, Supplies & Distribution | +0.27% | +7.54% | +10.94% | +49.92% | -32.76% | 10.22B |
- Stock Market
- Stocks
- RGEN Stock
- Charts Repligen Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















